Annual EPS
-$0.74
+$0.03+3.90%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual earnings per share is -$0.74, with the most recent change of +$0.03 (+3.90%) on December 31, 2023.
- During the last 3 years, OVID annual EPS has risen by +$0.65 (+46.76%).
- OVID annual EPS is now -142.05% below its all-time high of $1.76, reached on December 31, 2021.
Performance
OVID EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.20
-$0.32-266.67%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly earnings per share is -$0.20, with the most recent change of -$0.32 (-266.67%) on September 30, 2024.
- Over the past year, OVID quarterly EPS has increased by +$0.02 (+9.09%).
- OVID quarterly EPS is now -107.91% below its all-time high of $2.53, reached on March 31, 2021.
Performance
OVID Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$0.47
-$0.04-9.30%
September 30, 2024
Summary
- As of February 8, 2025, OVID TTM earnings per share is -$0.47, with the most recent change of -$0.04 (-9.30%) on September 30, 2024.
- Over the past year, OVID TTM EPS has increased by +$0.28 (+37.33%).
- OVID TTM EPS is now -126.26% below its all-time high of $1.79, reached on September 30, 2021.
Performance
OVID TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
OVID EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | +9.1% | +37.3% |
| 3 y3 years | +46.8% | +9.1% | +37.3% |
| 5 y5 years | +64.9% | +9.1% | +37.3% |
OVID EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -142.1% | +3.9% | -266.7% | +47.4% | -126.9% | +53.5% |
| 5 y | 5-year | -142.1% | +52.0% | -107.9% | +51.2% | -126.3% | +70.3% |
| alltime | all time | -142.1% | +77.9% | -107.9% | +85.6% | -126.3% | +83.2% |
Ovid Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.20(-266.7%) | -$0.47(+9.3%) |
| Jun 2024 | - | $0.12(-170.6%) | -$0.43(-41.1%) |
| Mar 2024 | - | -$0.17(-22.7%) | -$0.73(-2.7%) |
| Dec 2023 | -$0.74(-3.9%) | -$0.22(+37.5%) | -$0.75(+8.7%) |
| Sep 2023 | - | -$0.16(-11.1%) | -$0.69(-1.4%) |
| Jun 2023 | - | -$0.18(-5.3%) | -$0.70(-4.1%) |
| Mar 2023 | - | -$0.19(+18.8%) | -$0.73(-5.2%) |
| Dec 2022 | -$0.77(-143.8%) | -$0.16(-5.9%) | -$0.77(-22.2%) |
| Sep 2022 | - | -$0.17(-19.0%) | -$0.99(0.0%) |
| Jun 2022 | - | -$0.21(-8.7%) | -$0.99(-2.0%) |
| Mar 2022 | - | -$0.23(-39.5%) | -$1.01(-157.7%) |
| Dec 2021 | $1.76(-226.6%) | -$0.38(+123.5%) | $1.75(-2.2%) |
| Sep 2021 | - | -$0.17(-26.1%) | $1.79(+6.5%) |
| Jun 2021 | - | -$0.23(-109.1%) | $1.68(+12.0%) |
| Mar 2021 | - | $2.53(-844.1%) | $1.50(-207.1%) |
| Dec 2020 | -$1.39 | -$0.34(+21.4%) | -$1.40(-0.7%) |
| Sep 2020 | - | -$0.28(-31.7%) | -$1.41(-9.6%) |
| Jun 2020 | - | -$0.41(+10.8%) | -$1.56(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$0.37(+5.7%) | -$1.49(-5.7%) |
| Dec 2019 | -$1.54(-27.0%) | -$0.35(-18.6%) | -$1.58(-9.7%) |
| Sep 2019 | - | -$0.43(+26.5%) | -$1.75(-5.4%) |
| Jun 2019 | - | -$0.34(-26.1%) | -$1.85(-9.3%) |
| Mar 2019 | - | -$0.46(-11.5%) | -$2.04(-3.8%) |
| Dec 2018 | -$2.11(-37.0%) | -$0.52(-1.9%) | -$2.12(+3.4%) |
| Sep 2018 | - | -$0.53(0.0%) | -$2.05(+7.9%) |
| Jun 2018 | - | -$0.53(-1.9%) | -$1.90(-2.1%) |
| Mar 2018 | - | -$0.54(+20.0%) | -$1.94(-30.5%) |
| Dec 2017 | -$3.35(+193.0%) | -$0.45(+18.4%) | -$2.79(+2.4%) |
| Sep 2017 | - | -$0.38(-33.3%) | -$2.73(+3.2%) |
| Jun 2017 | - | -$0.57(-59.0%) | -$2.64(+12.6%) |
| Mar 2017 | - | -$1.39(+260.8%) | -$2.35(+105.3%) |
| Dec 2016 | -$1.14(+70.3%) | -$0.39(+30.7%) | -$1.14(+50.9%) |
| Sep 2016 | - | -$0.30(+7.4%) | -$0.76(+63.8%) |
| Jun 2016 | - | -$0.27(+46.3%) | -$0.46(+146.3%) |
| Mar 2016 | - | -$0.19 | -$0.19 |
| Dec 2015 | -$0.67 | - | - |
FAQ
- What is Ovid Therapeutics annual earnings per share?
- What is the all time high annual EPS for Ovid Therapeutics?
- What is Ovid Therapeutics annual EPS year-on-year change?
- What is Ovid Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly EPS year-on-year change?
- What is Ovid Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Ovid Therapeutics?
- What is Ovid Therapeutics TTM EPS year-on-year change?
What is Ovid Therapeutics annual earnings per share?
The current annual EPS of OVID is -$0.74
What is the all time high annual EPS for Ovid Therapeutics?
Ovid Therapeutics all-time high annual earnings per share is $1.76
What is Ovid Therapeutics annual EPS year-on-year change?
Over the past year, OVID annual earnings per share has changed by +$0.03 (+3.90%)
What is Ovid Therapeutics quarterly earnings per share?
The current quarterly EPS of OVID is -$0.20
What is the all time high quarterly EPS for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly earnings per share is $2.53
What is Ovid Therapeutics quarterly EPS year-on-year change?
Over the past year, OVID quarterly earnings per share has changed by +$0.02 (+9.09%)
What is Ovid Therapeutics TTM earnings per share?
The current TTM EPS of OVID is -$0.47
What is the all time high TTM EPS for Ovid Therapeutics?
Ovid Therapeutics all-time high TTM earnings per share is $1.79
What is Ovid Therapeutics TTM EPS year-on-year change?
Over the past year, OVID TTM earnings per share has changed by +$0.28 (+37.33%)